Validation of NIDA research marijuana for use in cardiovascular health studies


  1. Matt Springer, PhD
Research Fields: 
Secondhand Smoke

Due to the continued restrictions on US cannabis researchers to work only on DEA-approved research marijuana that does not completely reflect most "real world" marijuana being used, we have arranged to have NIDA provide us with small batches of research marijuana that more accurately reflect real-world chemical composition and cannabinoid levels.  We plan to characterize the cannabinoid and terpene profiles of these batches and to compare their cardiovascular effects to those of standard research marijuana in rats.